How much will Herceptin really cost?

Ann Barrett; Tom Roques; Matthew Small; Richard D Smith; (2006) How much will Herceptin really cost? BMJ, 333 (7578). pp. 1118-1120. ISSN 1468-5833 DOI: 10.1136/bmj.39008.624051.BE

Copy

New guidance from the National Institute for Health and Clinical Excellence recommends Herceptin in early breast cancer, but it provides no additional funding or any suggestion of which services to cut. This leaves medical staff with difficult decisions to make

Item Type	Article
Keywords	Antibodies, Monoclonal, economics, therapeutic use, Antineoplastic Agents, economics, therapeutic use, Breast Neoplasms, drug therapy, economics, Chemotherapy, Adjuvant, economics, Cost-Benefit Analysis, Drug Costs, Female, Humans
ISI	242520200021